Levolta Pharmaceuticals, Inc

Headquarters

Bethlehem, PA

Levolta Pharmaceuticals is an innovative, clinical-stage pharmaceutical company focused on the acquisition, development, and commercialization of medically important pharmaceutical products for the treatment of rheumatology, immunology, and cancer. The company is driven to overcome current treatment barriers by developing products with an enhanced therapeutic index that drive customer value. Its lead product, VOLT01, is a novel proprietary derivative of zoledronic acid (ZA) that has demonstrated enhanced efficacy and safety in treating osteoarthritis.

• MAXONA Pharmaceuticals, IncMAXONA Pharmaceuticals is a clinical-stage pharmaceutical company leveraging innovation to develop the next generation of therapies to help patients maximize life. MAXONA's initial focus is on addressing the urgent need for new effective therapies that treat acute and chronic pain, without the side effects and addiction risks associated with NSAIDS and opioids. MAXONA's lead compound, MAX-001 is a non-opioid, non-NSAID oral therapy with a novel mechanism of action that is initially being developed in the U.S. to treat acute and chronic pain.MALVERN, PA
• Tavotek BiotherapeuticsTavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company leverages proprietary antibody engineering platforms to generate high-affinity, high-specificity antibodies targeting disease-relevant antigens in Oncology and Immunology.LOWER GWYNEDD, PA
• Apozeal Pharmaceuticals IncApozeal Pharmaceuticals Inc. is a pharmaceutical company focused on the development and manufacturing of high-quality medicines. The company owns 10 FDA-approved ANDA products for the US market and operates a 75,000 sq. ft. cGMP manufacturing facility in Levittown, PA, with capabilities for oral liquid solutions, suspensions, and suppositories.LEVITTOWN, PA
• ZyVersa Therapeutics, IncZyVersa Therapeutics, Inc. is a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for inflammatory and renal diseases. It leverages two proprietary platforms: an inflammasome ASC inhibitor (IC 100) for inflammatory conditions and a cholesterol efflux mediator (VAR 200) for kidney diseases.WEST CONSHOHOCKEN, PA